Skip to Main Content

Paper Details

Four-year Prostate-specific Antigen Response Rate as a Predictive Measure in Intermediate-risk Prostate Cancer Treated With Ablative Therapies: The SPRAT Analysis.
Clin Oncol (R Coll Radiol)
2
2022
Author NameAffiliation
Rachel M GlicksmanUniversity of Toronto
Amar U KishanUniversity of California los angeles
Alan W KatzSt. Francis Hospital
Constantine A Mantz
Sean P CollinsGeorgetown University
Donald B Fuller
David ShabsovichUniversity of California los angeles
Andrew LoblawOdette Cancer Centre, Canada Institute of Health Policy, University of Toronto
  • 1 - 8

Datasets

Release 1.2